Inhibiting the expression of ITGB1-DT in gastric adenocarcinoma can help to inhibit the development and metastasis of gastric adenocarcinoma and reduce the occurrence of poor prognosis [16]. This evidence concerns the gene ITGB1 and gastric adenocarcinoma.